NCT06189105

Brief Summary

Niacinamide in lower concentrations has been recognized as a cosmetic ingredient with hydrating properties. Therefore, aim was to test the efficacy and safety of niacinamide cosmetic preparation in A Randomized, Controlled Trial.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 3, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 13, 2023

Completed
4 months until next milestone

First Posted

Study publicly available on registry

January 3, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

January 3, 2024

Status Verified

December 1, 2023

Enrollment Period

12 months

First QC Date

September 13, 2023

Last Update Submit

December 18, 2023

Conditions

Outcome Measures

Primary Outcomes (4)

  • TEWL assessment with Courage Khazaka probe

    Transepidermal water loss

    through study completion, an average of 1 year

  • Hydration assessment with corneometer probe

    stratum corneum hydration

    through study completion, an average of 1 year

  • pigmentation assessment with mexameter probe

    erythema and melanin

    through study completion, an average of 1 year

  • skin oiliness assessment with sebumeter probe

    sebum level

    through study completion, an average of 1 year

Secondary Outcomes (1)

  • subjective opinion of participants

    through study completion, an average of 1 year

Study Arms (2)

experimental arm

EXPERIMENTAL

Use of facial serum with niacinamide, plant-based collagen and peptides on randomized site on forehead

Other: miss alice face it you love me serum

placebo comparator

PLACEBO COMPARATOR

No treatment (usual skincare rutine)

Other: No treatment (usual skincare rutine)

Interventions

Facial serum with niacinamide, plant-based collagen and peptides will be applied by each participant to the treatment site according to randomization protocol every evening

experimental arm

No treatment (usual skincare rutine)

placebo comparator

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • healthy volunteers who gave written informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Split School of Medicine

Split, Croatia

RECRUITING

Related Publications (1)

  • Rusic D, Ivic M, Slugan A, Leskur D, Modun D, Durdov T, Vukovic D, Bukic J, Bozic J, Seselja Perisin A. Pilot Study on the Effects of a Cosmetic Serum Containing Niacinamide, Postbiotics and Peptides on Facial Skin in Healthy Participants: A Randomized Controlled Trial. Life (Basel). 2024 Dec 18;14(12):1677. doi: 10.3390/life14121677.

MeSH Terms

Conditions

HyperpigmentationEczema

Condition Hierarchy (Ancestors)

Pigmentation DisordersSkin DiseasesSkin and Connective Tissue DiseasesDermatitisSkin Diseases, Eczematous

Study Officials

  • Dario Leskur

    USSM

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant professor

Study Record Dates

First Submitted

September 13, 2023

First Posted

January 3, 2024

Study Start

June 3, 2023

Primary Completion

June 1, 2024

Study Completion

June 1, 2024

Last Updated

January 3, 2024

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will share

upon request

Shared Documents
CSR
Time Frame
upon request
Access Criteria
upon request

Locations